Sangamo BioSciences Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Sangamo Biosciences (SGMO) Tops Q1 EPS by 1c
May 2, 2016 4:13 PM EDTSangamo Biosciences (NASDAQ: SGMO) reported Q1 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $5.49 million.
GUIDANCE:
Sangamo Biosciences sees FY2016 revenue of $20-25 million, versus the consensus of... More
